DAVID NIELSEN to Pharmacogenetics
This is a "connection" page, showing publications DAVID NIELSEN has written about Pharmacogenetics.
Connection Strength
1.297
-
Pharmacogenetics of addiction therapy. Methods Mol Biol. 2014; 1175:589-624.
Score: 0.416
-
Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev. 2005 Mar; 57(1):1-26.
Score: 0.226
-
Pharmacogenetics of Addiction Therapy. Methods Mol Biol. 2022; 2547:437-490.
Score: 0.181
-
Doxazosin treatment in cocaine use disorder: pharmacogenetic response based on an alpha-1 adrenoreceptor subtype D genetic variant. Am J Drug Alcohol Abuse. 2020; 46(2):184-193.
Score: 0.158
-
Pharmacogenetic role of dopamine transporter (SLC6A3) variation on response to disulfiram treatment for cocaine addiction. Am J Addict. 2019 07; 28(4):311-317.
Score: 0.151
-
Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic system. Psychiatr Genet. 2015 Oct; 25(5):181-93.
Score: 0.118
-
The influence of dopamine ?-hydroxylase gene polymorphism rs1611115 on levodopa/carbidopa treatment for cocaine dependence: a preliminary study. Pharmacogenet Genomics. 2014 Jul; 24(7):370-3.
Score: 0.027
-
Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment. Ann N Y Acad Sci. 2010 Feb; 1187:184-207.
Score: 0.020